Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frances A Shepherd

Showing results (161-170 of 384) with videos related to

Pageof 39
Sort By:
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancerThomas J Lynch, David Fenton, Vera Hirsh, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
JTO Clinical and Research Reports|January 2, 2026
Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for <i>ALK-</i>Mutated NSCLCBeatriz Jimenez Munarriz, Sameena Khan, Katrina Hueniken, et al.
Journal of the National Cancer Institute|February 18, 2010
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancerPenelope A Bradbury, Dongsheng Tu, Lesley Seymour, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 28, 2020
The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world dataAli Vedadi, Sharara Shakik, M Catherine Brown, et al.
The Oncologist|September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Age-Related Patterns in Cancer Pain and Its Psychosocial Impact: Investigating the Role of Variability in Physical and Mental Health Quality of LifeLynn R Gauthier, Robert H Dworkin, David Warr, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray studyFiona H Blackhall, Dennis A Wigle, Igor Jurisica, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2007
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancerKarl L Uy, Gail Darling, Wei Xu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2011
A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancerPeter M Ellis, Normand Blais, Dennis Soulieres, et al.
Pageof 39

Showing results (161-170 of 384) with videos related to

Sort By:
Pageof 39
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|July 28, 2009
A randomized phase 2 study of erlotinib alone and in combination with bortezomib in previously treated advanced non-small cell lung cancerThomas J Lynch, David Fenton, Vera Hirsh, et al.
Lung Cancer (Amsterdam, Netherlands)|August 8, 2013
Cross-validation analysis of the prognostic significance of mucin expression in patients with resected non-small cell lung cancer treated with adjuvant chemotherapy: results from IALT, JBR.10 and ANITAStephen L Graziano, Benjamin Lacas, Robin Vollmer, et al.
JTO Clinical and Research Reports|January 2, 2026
Weight, BSA, Toxicity, and Efficacy of Tyrosine Kinase Inhibitors for <i>ALK-</i>Mutated NSCLCBeatriz Jimenez Munarriz, Sameena Khan, Katrina Hueniken, et al.
Journal of the National Cancer Institute|February 18, 2010
Economic analysis: randomized placebo-controlled clinical trial of erlotinib in advanced non-small cell lung cancerPenelope A Bradbury, Dongsheng Tu, Lesley Seymour, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|August 28, 2020
The impact of symptoms and comorbidity on health utility scores and health-related quality of life in small cell lung cancer using real world dataAli Vedadi, Sharara Shakik, M Catherine Brown, et al.
The Oncologist|September 28, 2017
Predictors of Venous Thromboembolism and Early Mortality in Lung Cancer: Results from a Global Prospective Study (CANTARISK)Nicole M Kuderer, Marek S Poniewierski, Eva Culakova, et al.
Pain Medicine (Malden, Mass.)|March 25, 2017
Age-Related Patterns in Cancer Pain and Its Psychosocial Impact: Investigating the Role of Variability in Physical and Mental Health Quality of LifeLynn R Gauthier, Robert H Dworkin, David Warr, et al.
Lung Cancer (Amsterdam, Netherlands)|October 12, 2004
Validating the prognostic value of marker genes derived from a non-small cell lung cancer microarray studyFiona H Blackhall, Dennis A Wigle, Igor Jurisica, et al.
The Journal of Thoracic and Cardiovascular Surgery|June 30, 2007
Improved results of induction chemoradiation before surgical intervention for selected patients with stage IIIA-N2 non-small cell lung cancerKarl L Uy, Gail Darling, Wei Xu, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|June 29, 2011
A systematic review and Canadian consensus recommendations on the use of biomarkers in the treatment of non-small cell lung cancerPeter M Ellis, Normand Blais, Dennis Soulieres, et al.
Pageof 39